Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Lowy

Showing results (261-270 of 401) with videos related to

Pageof 41
Sort By:
Science (New York, N.Y.)|December 4, 1987
Epidermal-growth-factor-dependent transformation by a human EGF receptor proto-oncogeneT J Velu, L Beguinot, W C Vass, et al.
The Journal of Biological Chemistry|January 24, 1997
Sequential modification of serines 621 and 624 in the Raf-1 carboxyl terminus produces alterations in its electrophoretic mobilityA F Ferrier, M Lee, W B Anderson, et al.
Journal of Virology|September 1, 1996
In vitro generation and type-specific neutralization of a human papillomavirus type 16 virion pseudotypeR B Roden, H L Greenstone, R Kirnbauer, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 25, 2006
Human alpha-defensins block papillomavirus infectionChristopher B Buck, Patricia M Day, Cynthia D Thompson, et al.
Immunity|July 2, 2020
The COVID-19 Serology Studies Workshop: Recommendations and ChallengesAndrea M Lerner, Robert W Eisinger, Douglas R Lowy, et al.
Nature Genetics|September 6, 2005
Sipa1 is a candidate for underlying the metastasis efficiency modifier locus Mtes1Yeong-Gwan Park, Xiaohong Zhao, Fabienne Lesueur, et al.
Clinical and Vaccine Immunology : CVI|May 18, 2012
A human papillomavirus (HPV) in vitro neutralization assay that recapitulates the in vitro process of infection provides a sensitive measure of HPV L2 infection-inhibiting antibodiesPatricia M Day, Yuk-Ying S Pang, Rhonda C Kines, et al.
Journal of Virology|September 1, 1993
Transformation-specific interaction of the bovine papillomavirus E5 oncoprotein with the platelet-derived growth factor receptor transmembrane domain and the epidermal growth factor receptor cytoplasmic domainB D Cohen, D J Goldstein, L Rutledge, et al.
Journal of Virology|June 8, 2007
Neutralization of human papillomavirus with monoclonal antibodies reveals different mechanisms of inhibitionPatricia M Day, Cynthia D Thompson, Christopher B Buck, et al.
Molecular and Cellular Biology|June 1, 1991
A ras effector domain mutant which is temperature sensitive for cellular transformation: interactions with GTPase-activating protein and NF-1J E DeClue, J C Stone, R A Blanchard, et al.
Pageof 41

Showing results (261-270 of 401) with videos related to

Sort By:
Pageof 41
Science (New York, N.Y.)|December 4, 1987
Epidermal-growth-factor-dependent transformation by a human EGF receptor proto-oncogeneT J Velu, L Beguinot, W C Vass, et al.
The Journal of Biological Chemistry|January 24, 1997
Sequential modification of serines 621 and 624 in the Raf-1 carboxyl terminus produces alterations in its electrophoretic mobilityA F Ferrier, M Lee, W B Anderson, et al.
Journal of Virology|September 1, 1996
In vitro generation and type-specific neutralization of a human papillomavirus type 16 virion pseudotypeR B Roden, H L Greenstone, R Kirnbauer, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 25, 2006
Human alpha-defensins block papillomavirus infectionChristopher B Buck, Patricia M Day, Cynthia D Thompson, et al.
Immunity|July 2, 2020
The COVID-19 Serology Studies Workshop: Recommendations and ChallengesAndrea M Lerner, Robert W Eisinger, Douglas R Lowy, et al.
Nature Genetics|September 6, 2005
Sipa1 is a candidate for underlying the metastasis efficiency modifier locus Mtes1Yeong-Gwan Park, Xiaohong Zhao, Fabienne Lesueur, et al.
Clinical and Vaccine Immunology : CVI|May 18, 2012
A human papillomavirus (HPV) in vitro neutralization assay that recapitulates the in vitro process of infection provides a sensitive measure of HPV L2 infection-inhibiting antibodiesPatricia M Day, Yuk-Ying S Pang, Rhonda C Kines, et al.
Journal of Virology|September 1, 1993
Transformation-specific interaction of the bovine papillomavirus E5 oncoprotein with the platelet-derived growth factor receptor transmembrane domain and the epidermal growth factor receptor cytoplasmic domainB D Cohen, D J Goldstein, L Rutledge, et al.
Journal of Virology|June 8, 2007
Neutralization of human papillomavirus with monoclonal antibodies reveals different mechanisms of inhibitionPatricia M Day, Cynthia D Thompson, Christopher B Buck, et al.
Molecular and Cellular Biology|June 1, 1991
A ras effector domain mutant which is temperature sensitive for cellular transformation: interactions with GTPase-activating protein and NF-1J E DeClue, J C Stone, R A Blanchard, et al.
Pageof 41